<?xml version="1.0" encoding="UTF-8"?><mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="id-2011-7313">
    <name type="corporate">
        <namePart>United States Government Publishing Office</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
            <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
        <role>
            <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
            <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>National Archives and Records Administration</namePart>
        <namePart>Office of the Federal Register</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">author</roleTerm>
            <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
        <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
        <collectionCode>FR</collectionCode>
        <category>Regulatory Information</category>
        <waisDatabaseName>2011_register</waisDatabaseName>
        <branch>executive</branch>
        <dateIngested>2011-03-29</dateIngested>
    </extension>
    <genre authority="marcgt">article</genre>
    <titleInfo>
        <title>New Animal Drugs; Amikacin Sulfate, Ampicillin Trihydrate, Ceftiofur Hydrochloride, Cephapirin Benzathine, Chlortetracycline, Fenbendazole, Formalin, Furosemide, Glucose/Glycine/Electrolyte, Pyrantel Pamoate, Sulfadimethoxine, Sulfamethazine, and Tetracycline</title>
        <partName>Rules and Regulations</partName>
    </titleInfo>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2011-03-29/html/2011-7313.htm">
        <identifier type="FDsys Unique ID">D09002ee1c800244d</identifier>
    </relatedItem>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2011-03-29/pdf/2011-7313.pdf">
        <identifier type="FDsys Unique ID">D09002ee1c800253e</identifier>
    </relatedItem>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Department of Health and Human Services</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Food and Drug Administration</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <abstract>The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect revised human food safety warnings or updated pathogen nomenclature on dosage form new animal drug product labeling that have not been codified. The regulations are also being amended to correct the wording of certain other conditions of use, to correct minor errors, and to revise some sections to reflect a current format. These actions are being taken to comply with the Federal Food, Drug, and Cosmetic Act (FD&amp;C Act) and to improve the accuracy and readability of the regulations.</abstract>
    <identifier type="FR citation">76 FR 17336</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/FR-2011-03-29/2011-7313</identifier>
    <identifier type="FR Doc No.">2011-7313</identifier>
    <identifier type="former granule identifier">fr29mr11-4</identifier>
    <identifier type="billing code">4160-01-P</identifier>
    <identifier type="department code">Docket No. FDA-2011-N-0003</identifier>
    <location>
        <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2011-03-29/2011-7313</url>
        <url access="raw object" displayLabel="HTML rendition">https://www.govinfo.gov/content/pkg/FR-2011-03-29/html/2011-7313.htm</url>
        <url access="raw object" displayLabel="PDF rendition">https://www.govinfo.gov/content/pkg/FR-2011-03-29/pdf/2011-7313.pdf</url>
    </location>
    <physicalDescription>
        <extent>4 p.</extent>
    </physicalDescription>
    <part type="Rules and Regulations">
        <extent unit="pages">
            <start>17336</start>
            <end>17339</end>
        </extent>
    </part>
    <identifier type="preferred citation">76 FR 17336</identifier>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 520</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  520</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 522</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  522</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 526</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  526</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 529</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  529</identifier>
    </relatedItem>
    <extension>
        <searchTitle>New Animal Drugs; Amikacin Sulfate, Ampicillin Trihydrate, Ceftiofur Hydrochloride, Cephapirin Benzathine, Chlortetracycline, Fenbendazole, Formalin, Furosemide, Glucose/Glycine/Electrolyte, Pyrantel Pamoate, Sulfadimethoxine, Sulfamethazine, and Tetracycline; Federal Register Vol. 76, Issue </searchTitle>
        <granuleClass>RULE</granuleClass>
        <accessId>2011-7313</accessId>
        <agency order="1">DEPARTMENT OF HEALTH AND HUMAN SERVICES</agency>
        <agency order="2">Food and Drug Administration</agency>
        <effectiveDate>2011-03-29</effectiveDate>
        <departmentDoc>Docket No. FDA-2011-N-0003</departmentDoc>
        <billingCode>4160-01-P</billingCode>
        <frDocNumber>2011-7313</frDocNumber>
        <action>Final rule; correcting amendments.</action>
        <summary>The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect revised human food safety warnings or updated pathogen nomenclature on dosage form new animal drug product labeling that have not been codified. The regulations are also being amended to correct the wording of certain other conditions of use, to correct minor errors, and to revise some sections to reflect a current format. These actions are being taken to comply with the Federal Food, Drug, and Cosmetic Act (FD&amp;C Act) and to improve the accuracy and readability of the regulations.</summary>
        <dates>This rule is effective March 29, 2011.</dates>
        <contact>George K. Haibel, Center for Veterinary Medicine (HFV-6), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9019, e-mail: george.haibel@fda.hhs.gov.</contact>
        <cfr title="21">
                                    
            <part number="520"/>
                                
        </cfr>
        <cfr title="21">
                                    
            <part number="522"/>
                                
        </cfr>
        <cfr title="21">
                                    
            <part number="526"/>
                                
        </cfr>
        <cfr title="21">
                                    
            <part number="529"/>
                                
        </cfr>
        <tocSubject1>New Animal Drugs:</tocSubject1>
        <tocDoc>Amikacin Sulfate, Ampicillin Trihydrate, Ceftiofur Hydrochloride, Cephapirin Benzathine, etc.; Correcting Amendments
, </tocDoc>
        <emailRef>george.haibel@fda.hhs.gov</emailRef>
    </extension>
    <relatedItem type="host" ID="P0b002ee180c94d60" xlink:href="https://www.govinfo.gov/metadata/pkg/FR-2011-03-29/mods.xml">
        <titleInfo>
            <title>Federal Register</title>
            <partNumber>Vol. 76, no. 60</partNumber>
        </titleInfo>
        <originInfo>
            <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
            <dateIssued encoding="w3cdtf">2011-03-29</dateIssued>
            <issuance>continuing</issuance>
            <frequency>daily</frequency>
        </originInfo>
        <physicalDescription>
            <note type="source content type">deposited</note>
            <digitalOrigin>born digital</digitalOrigin>
            <extent>205 p.</extent>
        </physicalDescription>
        <tableOfContents xlink:href="https://www.govinfo.gov/app/frtoc/2011-03-29">    
		  Table of Contents: 
		</tableOfContents>
        <classification authority="sudocs">AE 2.7:</classification>
        <classification authority="sudocs">GS 4.107:</classification>
        <classification authority="sudocs">AE 2.106:</classification>
        <classification authority="lcc">KF70.A2</classification>
        <identifier type="uri">https://www.govinfo.gov/app/details/FR-2011-03-29</identifier>
        <identifier type="local">P0b002ee180c94d60</identifier>
        <identifier type="issn">0097-6326</identifier>
        <identifier type="issn">0042-1219</identifier>
        <identifier type="issn">0364-1406</identifier>
        <identifier type="stock number">769-004-00000-9</identifier>
        <identifier type="ILS system id">000582072</identifier>
        <identifier type="former identifier">f:fr29mr11</identifier>
        <location>
            <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2011-03-29</url>
            <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2011-03-29/pdf/FR-2011-03-29.pdf</url>
            <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2011-03-29/xml/FR-2011-03-29.xml</url>
        </location>
        <accessCondition type="GPO scope determination">fdlp</accessCondition>
        <part type="issue">
            <extent unit="pages">
                <start>17327</start>
                <end>17520</end>
            </extent>
        </part>
        <recordInfo>
            <recordContentSource authority="marcorg">DGPO</recordContentSource>
            <recordCreationDate encoding="w3cdtf">2011-03-29</recordCreationDate>
            <recordChangeDate encoding="w3cdtf">2024-06-04</recordChangeDate>
            <recordIdentifier source="DGPO">FR-2011-03-29</recordIdentifier>
            <recordOrigin>machine generated</recordOrigin>
            <languageOfCataloging>
                <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
            </languageOfCataloging>
        </recordInfo>
        <extension>
            <docClass>FR</docClass>
            <accessId>FR-2011-03-29</accessId>
            <volume>76</volume>
            <issue>60</issue>
        </extension>
    </relatedItem>
</mods>
